| Literature DB >> 30327462 |
A M V Gerlicher1,2,3, O Tüscher4,5, R Kalisch6,4.
Abstract
Fear extinction does not prevent post-traumatic stress or have long-term therapeutic benefits in fear-related disorders unless extinction memories are easily retrieved at later encounters with the once-threatening stimulus. Previous research in rodents has pointed towards a role for spontaneous prefrontal activity occurring after extinction learning in stabilizing and consolidating extinction memories. In other memory domains spontaneous post-learning activity has been linked to dopamine. Here, we show that a neural activation pattern - evoked in the ventromedial prefrontal cortex (vmPFC) by the unexpected omission of the feared outcome during extinction learning - spontaneously reappears during postextinction rest. The number of spontaneous vmPFC pattern reactivations predicts extinction memory retrieval and vmPFC activation at test 24 h later. Critically, pharmacologically enhancing dopaminergic activity during extinction consolidation amplifies spontaneous vmPFC reactivations and correspondingly improves extinction memory retrieval at test. Hence, a spontaneous dopamine-dependent memory consolidation-based mechanism may underlie the long-term behavioral effects of fear extinction.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30327462 PMCID: PMC6191435 DOI: 10.1038/s41467-018-06785-y
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919
Fig. 1Experimental design and skin conductance responses. a Participants underwent a 3-day fMRI study with fear conditioning on day 1, extinction and subsequent placebo or l-DOPA administration on day 2 and test on day 3. During fear conditioning one of two geometric symbols (CS+) was reinforced with a painful electrical stimulation, while the other symbol (CS−) was never reinforced. Postextinction placebo or l-DOPA administration was randomized and double-blinded (placebo: n = 20, l-DOPA n = 20, all male, for group characteristics, see Supplementary Table 1). Resting-state fMRI scans (R) were acquired before and after fear conditioning, before and 10, 45, and 90 min after extinction, and before test. b During all experimental phases, we assessed conditioned responses (CRs) as skin conductance responses (SCRs) to CS+ and CS−. Upper panel depicts mean SCR to CS+ and CS− for placebo-, lower panel for l-DOPA-treated participants. The groups differed significantly on mean SCRs across the test phase on day 3 (marked by yellow line) due to significantly smaller mean SCRs to the CS+ in l-DOPA compared to placebo-treated participants. Note, that the group difference stemmed from significantly smaller CS+ evoked SCRs averaged across the whole test phase, but the speed of re-extinction did not differ significantly between drug groups (control analysis with stimulus (CS+, CS−) and trial (1–10) as within-, and group (placebo, l-DOPA) as between-subject factor: stimulus × group, F1,33 = 6.58, P = 0.02, partial η2 = 0.17; stimulus x trial x group, F9,297 = 1.32, P = 0.23; n = 35). Data are presented as mean ± standard error of the mean (s.e.m)
Fig. 2Spontaneous postextinction reactivations support extinction memory consolidation. a Temporal distribution of suprathreshold correlations between the spatial fMRI activity pattern in vmPFC evoked on day 2 during extinction by the unexpected US omission (CS+ offsets in early extinction, i.e., first five trials) and the vmPFC pattern occurring at each resting-state volume after extinction on the same day. Each column represents one participant. The bars to the right of each panel represent sum scores per 25 imaging volumes, for both the placebo (light gray) and the l-DOPA group (dark gray). b Relation between the number of potential spontaneous CS+ offset-related vmPFC pattern reactivations 45 min after extinction on day 2 (here and in further graphs expressed as log + 1; for control analyses on nonlog-transformed data, see Supplementary Figs. 2, 3) and CRs at test on day 3 in the whole sample. c The number of potential vmPFC pattern reactivations 45 min after extinction on day 2 predicts CS+ > CS− evoked activity in vmPFC during test on day 3 (SPM multiple regression: MNI x,y,z = 6,46,−14; Z = 3.86, P = 0.01; small-volume (SVC) and family-wise error (FWE) corrected; n = 40). Display threshold P < 0.05, SVC, FWE, no masking applied. d Relation between vmPFC activity and CRs at test on day 3 (Pearson correlation: r35 = −0.37, P = 0.03; n = 35). e Effect of l-DOPA administration after extinction on day 2 on the number of spontaneous reactivations of CS+ offset-related vmPFC patterns during subsequent resting-state scans. f There was no effect of l-DOPA on number of spontaneous reactivations of CS− offset-related vmPFC patterns during resting-state scans on day 2 (repeated-measures ANOVA: time × group: P = 0.63, group: P = 0.77; n = 40). g The postextinction administration of l-DOPA had a significant positive effect on number of potential CS+ offset-related vmPFC reactivations (path a: ß = 0.97, SE = 0.30, T33 = 3.23, P = 0.003; n = 35). The number of potential CS+ offset-related vmPFC reactivations 45 min after extinction was significantly negatively related to smaller differential CRs at test on day 3 (path b: β = −0.10, SE = 0.03, T = −4.26, P = 0.0002; n = 35). After inclusion of number of potential CS+ offset-related vmPFC reactivations into the latter model, the significant effect of drug on CRs at test (path c: ß = −0.15, SE = 0.06, T = −2.57, P = 0.02; n = 35) decreased (path c’: β = −0.06, SE = 0.06, T = −0.98, P = 0.33; n = 35), indicating that the effect of l-DOPA on CRs at test on day 3 was significantly mediated (c–c’ = −0.09, 95% CI: −0.13 to −0.02, P = 0.007; bootstrapping procedure with 10,000 simulations; n = 35) by number of potential CS+ offset-related vmPFC reactivations 45 min after extinction